We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > IRBM

News List

Merck, contract research firm IRBM partner on coronavirus therapies pharmaceutical-technology
July 22, 2020
Merck (MSD) has collaborated with contract research services company IRBM for the identification and development of new peptide therapeutics that can target various strains of coronavirus, including SARS-CoV-2.
Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax contractpharma
May 29, 2020
The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.
IRBM Signs Agreement with MD Anderson Cancer Center contractpharma
September 12, 2019
IRBM has signed a service and development agreement with The University of Texas MD Anderson Cancer Center.